FIELD: organic chemistry. SUBSTANCE: invention proposes new compounds of the formula (I): 
where: X means arbitrarily substituted benzimidazole group; Y means oxygen or sulfur atom; Z means 2,4-dioxothiazolidine-5-yl-indenylmethyl, 2,4-dioxo- -thiazolidine-5-yl-methyl, 2,4-dioxooxazolidine-5-yl-methyl, 3,5-dioxooxadiazolidine-2-yl-methyl or N-hydroxyureidomethyl group; R - hydrogen, alkyl, alkoxy, halide, hydroxy, nitro, amino or aralkyl-group; m = 1-5. Invention claims also a pharmaceutical composition based on compounds of the formula (I) taken at effective amount and containing an acceptable carrier or vehicle. Synthesized compounds show hypoglycaemic activity and capability to inhibit activity of aldosoreductase and 5-lipoxygenase and lipid peroxide production also. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 23 cl, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERMEDIATE COMPOUND FOR SYNTHESIS OF HETEROCYCLIC COMPOUNDS SHOWING ANTIDIABETIC ACTIVITY | 1995 |
|
RU2151145C1 |
| HETEROCYCLIC COMPOUNDS AND COMPOSITION ON SAID SHOWING ANTAGONISTIC EFFECT WITH RESPECT TO TACHYKININ RECEPTORS | 1996 |
|
RU2135494C1 |
| METHOD AND COMPOSITION FOR TREATING AND PREVENTING HYPERURICEMIA | 1998 |
|
RU2190425C2 |
| METHOD FOR OBTAINING LIPID A ANALOGUES | 0 |
|
SU1836378A3 |
| DERIVATIVES OF PHENYLALKYLCARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2169141C2 |
| LIPID ANALOGS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2076107C1 |
| SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE | 1998 |
|
RU2196141C2 |
| DERIVATIVES OF DITHIOLANE, MEDICINAL AGENTS | 1998 |
|
RU2169731C2 |
| DITHIOLANE DERIVATIVES AND DRUGS BASED ON THEREOF | 1998 |
|
RU2165932C2 |
| DERIVATIVES OF 1,2-DIPHENYLPYRROLE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2125044C1 |
